Sean T Turner

Title: The Innovations of Sean T. Turner

Introduction

Sean T. Turner is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific receptors in mammals. His work has implications for pain management and other medical conditions.

Latest Patents

One of Sean T. Turner's key patents is titled "Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof." This invention discloses fused thienopyridyl compounds of general formula (I), wherein X-X, R-R, Z, and L are defined in the description. The patent outlines a method for inhibiting the VR1 receptor in mammals using these compounds. It also describes methods for controlling pain, urinary incontinence, bladder overactivity, and inflammatory thermal hyperalgesia in mammals, along with pharmaceutical compositions that include these compounds. Sean holds 1 patent in this area.

Career Highlights

Sean T. Turner is currently employed at AbbVie Inc., a global biopharmaceutical company known for its innovative research and development in various therapeutic areas. His work at AbbVie has allowed him to focus on advancing medical treatments that improve patient outcomes.

Collaborations

Throughout his career, Sean has collaborated with several talented individuals, including Tammie K. Jinkerson and Arthur Gomtsyan. These collaborations have contributed to the success of his research and the development of impactful pharmaceutical solutions.

Conclusion

Sean T. Turner is a distinguished inventor whose work in developing thienopyridyl compounds has the potential to transform pain management and other medical treatments. His contributions to the field are noteworthy and continue to influence pharmaceutical innovation.